You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 4, 2026

Engineering Biological-Based Vascular Grafts Using a Pulsatile Bioreactor
Published on: June 14, 2011
Shuhei Tara1, Kevin A Rocco, Narutoshi Hibino
1Nationwide Children's Hospital.
Tissue-engineered vascular grafts (TEVG) show promise for cardiovascular disease. However, small-diameter arterial TEVG (<6mm) face challenges, requiring collaboration for clinical success.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: